Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Eur J Heart Fail. 2016 Sep 20;19(8):1027–1033. doi: 10.1002/ejhf.628

Table 2.

Comparison of Patients with a widened A-V O2 difference with normal and elevated plasma lactate levels

Variable Total (N=96) Lactate ≥2.1 (N=24) Lactate < 2.1 (N=72) P-value
Age, years 57.01 ± 11.04 53.98 ± 12.93 58.02 ± 10.24 0.12
Caucasian, No. (%) 70 (73%) 15 (63%) 55 (76%) 0.20
Male, No. (%) 74 (77%) 20 (83%) 54 (75%) 0.58
Bmi, Kg/m2 29.77 ± 5.93 29.70 ± 5.36 29.79 ± 6.15 0.95
Bsa, m2 2.07 ± 0.27 2.09 ± 0.27 2.06 ± 0.27 0.75
Intermacs profile, No. (%) 0.019
. Intermacs 1 45 (47%) 17 (71%) 28 (39%)
. Intermacs 2 45 (47%) 7 (29%) 38 (53%)
. Intermacs 3+ 6 (6%) 0 (0%) 6 (8%)
AVO2 7.63 ± 1.91 8.23 ± 1.97 7.43 ± 1.86 0.08
Lactate, Median (Q1, Q3) 1.5 (1.1, 2.1) 2.6 (2.3, 4.7) 1.3 (1.1, 1.6) <.001
RA pressure, mmHg 16.95 ± 8.68 17.79 ± 7.17 16.66 ± 9.16 0.58
Wedge pressure, mmHg 28.28 ± 8.15 27.52 ± 7.86 28.53 ± 8.28 0.61
Cardiac index, L/min m2 1.73 ± 0.44 1.58 ± 0.40 1.79 ± 0.45 0.049
Cardiac output, L/min 3.62 ± 1.10 3.37 ± 1.04 3.70 ± 1.11 0.21
LV EF, % 17.53 ± 6.83 16.48 ± 4.97 17.83 ± 7.28 0.43
LVEDD, cm 6.82 ± 1.16 6.75 ± 1.24 6.84 ± 1.14 0.75
RV TEI 0.65 ± 0.32 0.58 ± 0.22 0.67 ± 0.34 0.17
Continuous Inotropes 92.7% 91% 92.5% 0.74
Vasopressors 13.5% 20% 14.3% 0.48
INR 1.51 ± 0.44 1.71 ± 0.40 1.45 ± 0.43 0.012
Hemoglobin, mg/dl 10.79 ± 2.07 11.21 ± 2.58 10.61 ± 1.82 0.23
AST, U/L, Median (Q1, Q3) 47.0 (30.0, 142.0) 126.0 (41.5, 216.0) 42.0 (30.0, 83.0) 0.013
Glucose, mg/dl 173 ±74 175 ±60 173 ± 52 0.87
Albumin, g/dl 3.42 ± 0.47 3.23 ± 0.35 3.48 ± 0.49 0.026
Creatinine, g/dl 1.68 ± 0.75 1.72 ± 0.60 1.66 ± 0.79 0.71